FDA Approved: ZOCOR — Supplemental Application (Organon LLC)

View source ↗

Summary

FDA approved a supplemental application for ZOCOR (simvastatin) submitted by Organon LLC to the existing NDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Dyslipidemia
• Hypercholesterolemia
• Hyperlipidemia

Drugs mentioned

• Zocor (simvastatin)

Snippet

SUPPL AP for ZOCOR (SIMVASTATIN)